Folding screening assayed by proteolysis: application to various cystine deletion mutants of vascular endothelial growth factor.
about
Human C4b-binding protein, structural basis for interaction with streptococcal M protein, a major bacterial virulence factorThe cystine knot promotes folding and not thermodynamic stability in vascular endothelial growth factorIdentification of a Novel TGF-β-Binding Site in the Zona Pellucida C-terminal (ZP-C) Domain of TGF-β-Receptor-3 (TGFR-3)Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase familyTools to evaluate the conformation of protein products.Development and characterization of an automated high throughput screening method for optimization of protein refolding processes.Cytotoxic aggregation and amyloid formation by the myostatin precursor proteinEnhanced Mitogenic Activity of Recombinant Human Vascular Endothelial Growth Factor VEGF121 Expressed in E. coli Origami B (DE3) with Molecular Chaperones.αB-crystallin, an effector of unfolded protein response, confers anti-VEGF resistance to breast cancer via maintenance of intracrine VEGF in endothelial cells.Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.An automated in vitro protein folding screen applied to a human dynactin subunit.Two-faced Fcab prevents polymerization with VEGF and reveals thermodynamics and the 2.15 Å crystal structure of the complex.Conserved high affinity ligand binding and membrane association in the native and refolded extracellular domain of the human glycine receptor alpha1-subunit.Crohn's Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70.
P2860
Q24298062-34E96AC2-2E95-4F0A-B8B8-9B1F2D5FCA03Q24305927-734024A8-F074-4830-A0FB-C14C2EFEC55BQ27312359-8E2F2FC7-6BCD-42F9-80EC-943AECE1FA45Q27642567-13F793B0-7525-424D-A223-B6674EAC33BAQ30402632-20477645-6B0A-4C36-B981-6682B9F0D52CQ30419528-1C4E6949-5046-4D1B-906E-0040E6E1D2A9Q33531807-2C91720F-BD62-4D8D-B9A2-EF072245AABFQ36157482-5B88DDCF-C99B-4AEC-960D-B03BCA15D4EFQ36838575-15CE0134-FFAB-4BB9-AD17-0D29CE56938BQ38753508-0FAACC59-C861-4E6D-BE61-46C79C440F53Q42072527-4DA01BFD-BB09-4E26-829C-C552BDE829ABQ42075218-C569969F-F6E2-4859-BEB9-B42CCBD7A479Q44639270-A4238CFA-E18F-4C4B-A781-6D7553D1DF59Q47973286-DD61EBD0-36A1-4482-98BF-5181607731BE
P2860
Folding screening assayed by proteolysis: application to various cystine deletion mutants of vascular endothelial growth factor.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
2001年學術文章
@zh-hk
name
Folding screening assayed by p ...... lar endothelial growth factor.
@en
Folding screening assayed by p ...... lar endothelial growth factor.
@nl
type
label
Folding screening assayed by p ...... lar endothelial growth factor.
@en
Folding screening assayed by p ...... lar endothelial growth factor.
@nl
prefLabel
Folding screening assayed by p ...... lar endothelial growth factor.
@en
Folding screening assayed by p ...... lar endothelial growth factor.
@nl
P2860
P356
P1476
Folding screening assayed by p ...... lar endothelial growth factor.
@en
P2093
P2860
P304
P356
10.1093/PROTEIN/14.3.183
P577
2001-03-01T00:00:00Z